JP2001525816A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001525816A5 JP2001525816A5 JP1998548911A JP54891198A JP2001525816A5 JP 2001525816 A5 JP2001525816 A5 JP 2001525816A5 JP 1998548911 A JP1998548911 A JP 1998548911A JP 54891198 A JP54891198 A JP 54891198A JP 2001525816 A5 JP2001525816 A5 JP 2001525816A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85488197A | 1997-05-12 | 1997-05-12 | |
| US08/854,881 | 1997-05-12 | ||
| PCT/GB1998/001343 WO1998051344A1 (en) | 1997-05-12 | 1998-05-12 | Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001525816A JP2001525816A (ja) | 2001-12-11 |
| JP2001525816A5 true JP2001525816A5 (https=) | 2005-12-02 |
Family
ID=25319772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54891198A Withdrawn JP2001525816A (ja) | 1997-05-12 | 1998-05-12 | 治療における腫瘍壊死因子アルファおよび血管内皮成長因子の抑制 |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP0980258A1 (https=) |
| JP (1) | JP2001525816A (https=) |
| AU (1) | AU7345798A (https=) |
| CA (1) | CA2290021A1 (https=) |
| HK (1) | HK1044887A1 (https=) |
| WO (1) | WO1998051344A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030225254A1 (en) | 1989-08-07 | 2003-12-04 | Rathjen Deborah Ann | Tumour necrosis factor binding ligands |
| DE69027121T3 (de) | 1989-08-07 | 2001-08-30 | Peptech Ltd., Dee Why | Bindeligande für tumornekrosisfaktor |
| US7192584B2 (en) | 1991-03-18 | 2007-03-20 | Centocor, Inc. | Methods of treating psoriasis with anti-TNF antibodies |
| EP1049773B1 (en) | 1998-01-22 | 2007-07-25 | Btg International Limited | Inhibition of cytokine production |
| DK1159003T3 (da) * | 1999-03-02 | 2011-02-07 | Centocor Inc | Anti-tnfalfa-antistoffer til terapi af steroid-resistent astma |
| US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
| US7662367B2 (en) | 2000-03-02 | 2010-02-16 | Xencor, Inc. | Pharmaceutical compositions for the treatment of TNF-α related disorders |
| US7101974B2 (en) | 2000-03-02 | 2006-09-05 | Xencor | TNF-αvariants |
| JP2003525612A (ja) * | 2000-03-02 | 2003-09-02 | ゼンコー | ＴＮＦ−α関連障害の処置のための変種ＴＮＦ−αタンパク質の設計および発見 |
| US7244823B2 (en) | 2000-03-02 | 2007-07-17 | Xencor | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
| US7687461B2 (en) | 2000-03-02 | 2010-03-30 | Xencor, Inc. | Treatment of TNF-α related disorders with TNF-α variant proteins |
| US7446174B2 (en) | 2001-03-02 | 2008-11-04 | Xencor, Inc. | Protein based TNF-α variants for the treatment of TNF-α related disorders |
| US7056695B2 (en) | 2000-03-02 | 2006-06-06 | Xencor | TNF-α variants |
| US9028822B2 (en) | 2002-06-28 | 2015-05-12 | Domantis Limited | Antagonists against TNFR1 and methods of use therefor |
| US20040219142A1 (en) * | 2002-07-19 | 2004-11-04 | Abbott Laboratories S.A. | Treatment of skin and nail disorders using TNFalpha inhibitors |
| JP2006510606A (ja) | 2002-10-15 | 2006-03-30 | セルジーン・コーポレーション | 骨髄異形成症候群を治療および管理するための選択的サイトカイン阻害剤の使用方法およびそれを含む組成物 |
| US7101978B2 (en) | 2003-01-08 | 2006-09-05 | Applied Molecular Evolution | TNF-α binding molecules |
| EP1660504B1 (en) | 2003-08-29 | 2008-10-29 | Pfizer Inc. | Thienopyridine-phenylacet amides and their derivatives useful as new anti-angiogenic agents |
| WO2005041877A2 (en) * | 2003-10-29 | 2005-05-12 | Children's Medical Center Corporation | Method of inhibiting rejection following organ transplantation |
| EA009994B1 (ru) | 2003-12-23 | 2008-06-30 | Пфайзер Инк. | Новые хинолиновые производные |
| US7435799B2 (en) | 2004-01-08 | 2008-10-14 | Applied Molecular Evolution | TNF-α binding molecules |
| CN102961746B (zh) | 2005-05-16 | 2016-06-15 | 艾伯维生物技术有限公司 | TNFα抑制剂治疗腐蚀性多关节炎的用途 |
| JP2008120722A (ja) * | 2006-11-10 | 2008-05-29 | Benesis Corp | 生物由来製品の偽薬 |
| CN102612381B (zh) | 2009-03-20 | 2015-09-09 | 安塔瑞斯制药公司 | 危险试剂注入系统 |
| EP2704835A4 (en) | 2011-05-06 | 2014-12-24 | Bio Rad Laboratories | THERMOCYCLE COMPRISING A STEAM CHAMBER FOR RAPID TEMPERATURE CHANGES |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1097945B1 (en) * | 1991-03-18 | 2007-07-04 | New York University | Monoclonal and chimeric antibody specific for human tumor necrosis factor |
| KR100232688B1 (ko) * | 1992-09-15 | 1999-12-01 | 스코트 쥐. 홀퀴스트 | 종양 괴사 인자 길항제를 함유하는 tnf-의존성 염증 치료용 제약 조성물 |
| US6270766B1 (en) * | 1992-10-08 | 2001-08-07 | The Kennedy Institute Of Rheumatology | Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease |
| BR9207175A (pt) * | 1992-10-28 | 1995-12-12 | Genentech Inc | Composição contendo antagonista de fator de crescimento de célula endotelial vascular sequência aminoácida de anticorpo monoclonal polipeptídeo e método de tratamento de tumor em mamífero |
| US7608262B2 (en) * | 1996-02-16 | 2009-10-27 | The Kennedy Institute Of Rheumatology | Methods of preventing or treating thrombosis with tumor necrosis factor antagonists |
-
1998
- 1998-05-12 EP EP98920669A patent/EP0980258A1/en not_active Ceased
- 1998-05-12 JP JP54891198A patent/JP2001525816A/ja not_active Withdrawn
- 1998-05-12 AU AU73457/98A patent/AU7345798A/en not_active Abandoned
- 1998-05-12 WO PCT/GB1998/001343 patent/WO1998051344A1/en not_active Ceased
- 1998-05-12 EP EP01117491A patent/EP1170017A1/en not_active Withdrawn
- 1998-05-12 CA CA002290021A patent/CA2290021A1/en not_active Abandoned
-
2002
- 2002-07-09 HK HK02105101.3A patent/HK1044887A1/en unknown